4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-122274
General Counsel and Secretary sold 3,182 shares at $46.78 ($148,854)
- General Counsel and Secretary acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KASINGER JAMES R. · General Counsel and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-20 | Exercise or conversion : show line 1 in the form | +6,250 | 97,490 | D | ||
| 2026-03-23 | Sale : show line 2 in the form | −3,182 | $46.78 | $148,854 | 94,308 | D |
| Open-market sales · 3,182 sh · avg $46.78 · $148,854 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-20 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +38,499 | 38,499 | D |
| 2026-03-20 | Grant or award : show line 4 in the form Restricted Stock Units | +25,000 | 25,000 | D |
| 2026-03-20 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −6,250 | 12,000 | D |
Loading xslF345X06/ownership.xml…